GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 812 filers reported holding GLAXOSMITHKLINE PLC in Q4 2020. The put-call ratio across all filers is 1.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $1,105,438 | +238.1% | 25,362 | +240.4% | 0.02% | +200.0% |
| Q1 2022 | $327,000 | -3.0% | 7,451 | -1.9% | 0.01% | 0.0% |
| Q4 2021 | $337,000 | +27.2% | 7,592 | +9.7% | 0.01% | 0.0% |
| Q3 2021 | $265,000 | -25.1% | 6,918 | -21.8% | 0.01% | -27.3% |
| Q2 2021 | $354,000 | +57.3% | 8,850 | +40.5% | 0.01% | +37.5% |
| Q1 2021 | $225,000 | -8.9% | 6,301 | +12.5% | 0.01% | -20.0% |
| Q4 2020 | $247,000 | +201.2% | 5,599 | +155.2% | 0.01% | +11.1% |
| Q3 2020 | $82,000 | +34.4% | 2,194 | +48.2% | 0.01% | +28.6% |
| Q2 2020 | $61,000 | -4.7% | 1,480 | -11.3% | 0.01% | -22.2% |
| Q1 2020 | $64,000 | -88.6% | 1,668 | +39.6% | 0.01% | +50.0% |
| Q4 2019 | $561,000 | +819.7% | 1,195 | -16.6% | 0.01% | -25.0% |
| Q3 2019 | $61,000 | +27.1% | 1,433 | +21.4% | 0.01% | +33.3% |
| Q2 2019 | $48,000 | -14.3% | 1,180 | -13.0% | 0.01% | -14.3% |
| Q1 2019 | $56,000 | +24.4% | 1,357 | +16.8% | 0.01% | -46.2% |
| Q4 2018 | $45,000 | +125.0% | 1,162 | +137.1% | 0.01% | +116.7% |
| Q3 2018 | $20,000 | 0.0% | 490 | 0.0% | 0.01% | -60.0% |
| Q2 2018 | $20,000 | -31.0% | 490 | -33.2% | 0.02% | -6.2% |
| Q1 2018 | $29,000 | +70.6% | 734 | +49.8% | 0.02% | +77.8% |
| Q4 2017 | $17,000 | -15.0% | 490 | 0.0% | 0.01% | -50.0% |
| Q3 2017 | $20,000 | -20.0% | 490 | -16.9% | 0.02% | +63.6% |
| Q2 2017 | $25,000 | 0.0% | 590 | 0.0% | 0.01% | -21.4% |
| Q1 2017 | $25,000 | +19.0% | 590 | +20.4% | 0.01% | -36.4% |
| Q3 2016 | $21,000 | 0.0% | 490 | 0.0% | 0.02% | +10.0% |
| Q2 2016 | $21,000 | +5.0% | 490 | 0.0% | 0.02% | -51.2% |
| Q1 2016 | $20,000 | +233.3% | 490 | +206.2% | 0.04% | +156.2% |
| Q3 2015 | $6,000 | -14.3% | 160 | 0.0% | 0.02% | +33.3% |
| Q2 2015 | $7,000 | 0.0% | 160 | 0.0% | 0.01% | +9.1% |
| Q1 2015 | $7,000 | 0.0% | 160 | 0.0% | 0.01% | -54.2% |
| Q4 2014 | $7,000 | -50.0% | 160 | -50.0% | 0.02% | +26.3% |
| Q3 2014 | $14,000 | +55.6% | 320 | +100.0% | 0.02% | -26.9% |
| Q2 2014 | $9,000 | 0.0% | 160 | 0.0% | 0.03% | +13.0% |
| Q1 2014 | $9,000 | 0.0% | 160 | 0.0% | 0.02% | +15.0% |
| Q4 2013 | $9,000 | +800.0% | 160 | +595.7% | 0.02% | +1900.0% |
| Q2 2013 | $1,000 | – | 23 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
| Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
| KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
| Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
| Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
| EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
| Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
| Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
| CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
| CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |